CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.65
-0.38 (-0.49%)
Aug 12, 2026, 2:46 PM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $6.79 billion as of August 12, 2026. Its market cap has increased by 272.14% in one year.
Market Cap
6.79B
Enterprise Value
5.77B
1-Year Change
272.14%
Ranking
Category
Stock Price
$76.65
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $6.79B, an increase of 463.30%. That is a compound annual growth rate of 97.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 6.79B | 102.86% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 7.08B |
| Belite Bio | 6.99B |
| Oruka Therapeutics | 6.93B |
| Cogent Biosciences | 6.72B |
| Caris Life Sciences | 6.54B |
| Mirum Pharmaceuticals | 6.38B |
| Erasca | 6.36B |
| Scholar Rock Holding | 6.34B |